BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29604970)

  • 1. Central nervous system infection with Toxoplasma gondii.
    Marra CM
    Handb Clin Neurol; 2018; 152():117-122. PubMed ID: 29604970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Toxoplasma brain abscess with clindamycin and sulfadiazine in an AIDS patient with concurrent atypical Pneumocystis carinii pneumonia.
    Tsai HC; Lee SS; Lin HH; Lin WR; Chen YS; Huang CK; Liu YC; Chen ER
    J Formos Med Assoc; 2002 Sep; 101(9):646-9. PubMed ID: 12645193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxoplasma encephalitis in an HIV-infected patient on highly active antiretroviral therapy despite sustained immune response.
    Atreya AR; Arora S; Gadiraju VT; Martagon-Villamil J; Skiest DJ
    Int J STD AIDS; 2014 Apr; 25(5):383-6. PubMed ID: 24108450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections.
    Li Y; Zeng YM; Lu YQ; Qin YY; Chen YK
    Medicine (Baltimore); 2020 May; 99(20):e20146. PubMed ID: 32443329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Clindamycin and Azithromycin as Alternative Treatment for Toxoplasma gondii Encephalitis.
    Shiojiri D; Kinai E; Teruya K; Kikuchi Y; Oka S
    Emerg Infect Dis; 2019 Apr; 25(4):841-843. PubMed ID: 30882331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease.
    Vidal JE
    J Int Assoc Provid AIDS Care; 2019; 18():2325958219867315. PubMed ID: 31429353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral toxoplasmosis in HIV-infected patients: a review.
    Dian S; Ganiem AR; Ekawardhani S
    Pathog Glob Health; 2023 Feb; 117(1):14-23. PubMed ID: 35694771
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of alternative treatment approach for cerebral toxoplasmosis among HIV/AIDS patients from a resource-poor setting in Burkina Faso.
    Bamba S; Zoungrana J; Nikièma Z; Sondo AK; Ndiaye JL; Bretagne S
    Ann Parasitol; 2017; 63(3):173–181. PubMed ID: 29274210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus.
    Richards FO; Kovacs JA; Luft BJ
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S49-56. PubMed ID: 8547512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary study of the frequency of focal neurological deficits in HIV/AIDS patients seropositive for Toxoplasma gondii IgG in Lagos, Nigeria.
    Oshinaike OO; Okubadejo NU; Ojini FI; Danesi MA
    Nig Q J Hosp Med; 2010; 20(3):104-7. PubMed ID: 21033315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cerebral toxoplasmosis in patients with human immunodeficiency virus (HIV) infection. Clinico-radiological and therapeutic aspects in 63 patients].
    Ferrer S; Fuentes I; Domingo P; Muñoz C; Iranzo A; Barrio JL; Fuster M; Ris J; Sambeat MA; Cadafalch J; Nolla J
    An Med Interna; 1996 Jan; 13(1):4-8. PubMed ID: 8679824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal cord toxoplasmosis in human immunodeficiency virus infection/acquired immunodeficiency syndrome.
    García-García C; Castillo-Álvarez F; Azcona-Gutiérrez JM; Herraiz MJ; Ibarra V; Oteo JA
    Infect Dis (Lond); 2015 May; 47(5):277-82. PubMed ID: 25835092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients.
    Laing RB; Flegg PJ; Brettle RP; Leen CL; Burns SM
    Int J STD AIDS; 1996 Jul; 7(4):258-64. PubMed ID: 8876356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in toxoplasmosis.
    McCabe R; Chirurgi V
    Infect Dis Clin North Am; 1993 Sep; 7(3):587-604. PubMed ID: 8254161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cases of Toxoplasma gondii infection in foetus's and toxoplasmic encephalitis in immunosupressed patients confirmed by PCR method in NIPH - NIH, 2009-2010].
    Rozej-Bielicka W; Waloch M; Gołab E
    Przegl Epidemiol; 2011; 65(4):593-7. PubMed ID: 22390045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro.
    Wang JL; Elsheikha HM; Li TT; He JJ; Bai MJ; Liang QL; Zhu XQ; Cong W
    Int J Antimicrob Agents; 2019 Dec; 54(6):814-819. PubMed ID: 31479744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of HIV-associated central nervous system toxoplasmosis.
    Marra CM; Krone MR; Koutsky LA; Holmes KK
    Int J STD AIDS; 1998 Dec; 9(12):761-4. PubMed ID: 9874125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.
    Cohn JA; McMeeking A; Cohen W; Jacobs J; Holzman RS
    Am J Med; 1989 May; 86(5):521-7. PubMed ID: 2712059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
    Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma gondii infection in advanced HIV infection.
    Oksenhendler E; Charreau I; Tournerie C; Azihary M; Carbon C; Aboulker JP
    AIDS; 1994 Apr; 8(4):483-7. PubMed ID: 8011251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.